"Liposarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (LIPOSARCOMA, MYXOID), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed)
| Descriptor ID |
D008080
|
| MeSH Number(s) |
C04.557.450.550.420 C04.557.450.795.465
|
| Concept/Terms |
Liposarcoma, Dedifferentiated- Liposarcoma, Dedifferentiated
- Dedifferentiated Liposarcoma
- Dedifferentiated Liposarcomas
- Liposarcomas, Dedifferentiated
Liposarcoma, Pleomorphic- Liposarcoma, Pleomorphic
- Liposarcomas, Pleomorphic
- Pleomorphic Liposarcoma
- Pleomorphic Liposarcomas
|
Below are MeSH descriptors whose meaning is more general than "Liposarcoma".
Below are MeSH descriptors whose meaning is more specific than "Liposarcoma".
This graph shows the total number of publications written about "Liposarcoma" by people in this website by year, and whether "Liposarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 2 | 4 |
| 2018 | 3 | 0 | 3 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Liposarcoma" by people in Profiles.
-
Pleomorphic liposarcoma of the male breast: lessons from a rare malignancy during COVID-19 pandemic. BMJ Case Rep. 2021 Jul 20; 14(7).
-
Challenging retrovesical mass in men: report of a rare liposarcoma case with concurrent COVID-19 infection. BMJ Case Rep. 2021 Mar 02; 14(3).
-
Treatment of advanced soft tissue sarcoma by histological subtype: wish, prediction or reality? Future Oncol. 2019 Sep; 15(26s):5-10.
-
SBF-1 preferentially inhibits growth of highly malignant human liposarcoma cells. J Pharmacol Sci. 2018 Dec; 138(4):271-278.
-
Gastric Cardia Cancer Masquerading as a Fundic Subepithelial Tumor. Am J Gastroenterol. 2018 10; 113(10):1428.
-
Fatty Images of the Heart: Spectrum of Normal and Pathological Findings by Computed Tomography and Cardiac Magnetic Resonance Imaging. Biomed Res Int. 2018; 2018:5610347.
-
MDM4 amplification in a case of de-differentiated liposarcoma and in-silico data supporting an oncogenic event alternative to MDM2 amplification in a subset of cases. Histopathology. 2017 12; 71(6):1019-1023.
-
Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine. J Clin Oncol. 2017 Oct 20; 35(30):3433-3439.
-
REGOSARC: Regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-A quality-adjusted time without symptoms of progression or toxicity analysis. Cancer. 2017 Jun 15; 123(12):2294-2302.
-
Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort). PLoS One. 2017; 12(2):e0158406.